CN105012727B - 一种全天然男性性促进剂及其生产工艺 - Google Patents
一种全天然男性性促进剂及其生产工艺 Download PDFInfo
- Publication number
- CN105012727B CN105012727B CN201510390635.1A CN201510390635A CN105012727B CN 105012727 B CN105012727 B CN 105012727B CN 201510390635 A CN201510390635 A CN 201510390635A CN 105012727 B CN105012727 B CN 105012727B
- Authority
- CN
- China
- Prior art keywords
- extract
- accelerating agent
- crushed
- moisture
- property
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000005516 engineering process Methods 0.000 title claims abstract description 8
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 7
- 239000000284 extract Substances 0.000 claims abstract description 89
- 235000007320 Avena fatua Nutrition 0.000 claims abstract description 31
- 235000004535 Avena sterilis Nutrition 0.000 claims abstract description 31
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 30
- 240000000249 Morus alba Species 0.000 claims abstract description 28
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 28
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 25
- 239000002994 raw material Substances 0.000 claims abstract description 21
- 239000000463 material Substances 0.000 claims abstract description 20
- 241000234282 Allium Species 0.000 claims abstract description 14
- 241000209764 Avena fatua Species 0.000 claims abstract description 14
- 239000004480 active ingredient Substances 0.000 claims abstract description 14
- 210000000582 semen Anatomy 0.000 claims abstract description 14
- 241000190633 Cordyceps Species 0.000 claims abstract description 13
- 239000004615 ingredient Substances 0.000 claims abstract description 12
- 235000013305 food Nutrition 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 claims abstract description 7
- 231100000252 nontoxic Toxicity 0.000 claims abstract description 7
- 230000003000 nontoxic effect Effects 0.000 claims abstract description 7
- 239000002985 plastic film Substances 0.000 claims abstract description 7
- 229920006255 plastic film Polymers 0.000 claims abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 21
- 240000006108 Allium ampeloprasum Species 0.000 claims description 18
- 235000005254 Allium ampeloprasum Nutrition 0.000 claims description 18
- 238000002360 preparation method Methods 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 241001647031 Avena sterilis Species 0.000 claims description 17
- 238000001035 drying Methods 0.000 claims description 17
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 14
- 230000001954 sterilising effect Effects 0.000 claims description 14
- 235000009496 Juglans regia Nutrition 0.000 claims description 12
- 235000020234 walnut Nutrition 0.000 claims description 12
- 238000004659 sterilization and disinfection Methods 0.000 claims description 11
- 238000001914 filtration Methods 0.000 claims description 10
- 239000008280 blood Substances 0.000 claims description 7
- 210000004369 blood Anatomy 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 7
- 239000010941 cobalt Substances 0.000 claims description 6
- 229910017052 cobalt Inorganic materials 0.000 claims description 6
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims description 6
- 238000001238 wet grinding Methods 0.000 claims description 4
- 241000209140 Triticum Species 0.000 claims description 3
- 210000005069 ears Anatomy 0.000 claims description 3
- 239000011521 glass Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 235000021307 Triticum Nutrition 0.000 claims description 2
- 229910001220 stainless steel Inorganic materials 0.000 claims description 2
- 239000010935 stainless steel Substances 0.000 claims description 2
- 240000007049 Juglans regia Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 25
- 230000036299 sexual function Effects 0.000 abstract description 7
- 230000009286 beneficial effect Effects 0.000 abstract description 4
- 230000001737 promoting effect Effects 0.000 abstract description 4
- 235000019658 bitter taste Nutrition 0.000 abstract description 3
- 230000003014 reinforcing effect Effects 0.000 abstract description 3
- 230000009977 dual effect Effects 0.000 abstract description 2
- 238000001291 vacuum drying Methods 0.000 abstract description 2
- 239000003814 drug Substances 0.000 description 23
- 210000003734 kidney Anatomy 0.000 description 17
- 235000018102 proteins Nutrition 0.000 description 13
- 102000004169 proteins and genes Human genes 0.000 description 13
- 108090000623 proteins and genes Proteins 0.000 description 13
- 230000006870 function Effects 0.000 description 12
- 241000758789 Juglans Species 0.000 description 11
- 239000000047 product Substances 0.000 description 9
- 238000005728 strengthening Methods 0.000 description 9
- 235000001014 amino acid Nutrition 0.000 description 8
- 150000001413 amino acids Chemical class 0.000 description 8
- 235000016709 nutrition Nutrition 0.000 description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 7
- 239000011575 calcium Substances 0.000 description 7
- 229910052791 calcium Inorganic materials 0.000 description 7
- 235000001465 calcium Nutrition 0.000 description 7
- 235000019441 ethanol Nutrition 0.000 description 7
- 230000001568 sexual effect Effects 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 description 6
- 239000008101 lactose Substances 0.000 description 6
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 6
- 239000008108 microcrystalline cellulose Substances 0.000 description 6
- 229940016286 microcrystalline cellulose Drugs 0.000 description 6
- 239000011707 mineral Substances 0.000 description 6
- 235000010755 mineral Nutrition 0.000 description 6
- 239000011701 zinc Substances 0.000 description 6
- 229910052725 zinc Inorganic materials 0.000 description 6
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 102000004196 processed proteins & peptides Human genes 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 208000012201 sexual and gender identity disease Diseases 0.000 description 5
- 208000015891 sexual disease Diseases 0.000 description 5
- 239000011573 trace mineral Substances 0.000 description 5
- 235000013619 trace mineral Nutrition 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 102000004882 Lipase Human genes 0.000 description 4
- 108090001060 Lipase Proteins 0.000 description 4
- 239000004367 Lipase Substances 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- 230000000857 drug effect Effects 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 235000019421 lipase Nutrition 0.000 description 4
- DEIYFTQMQPDXOT-UHFFFAOYSA-N sildenafil citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 DEIYFTQMQPDXOT-UHFFFAOYSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 206010020565 Hyperaemia Diseases 0.000 description 3
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 3
- 201000001880 Sexual dysfunction Diseases 0.000 description 3
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 3
- 229930003451 Vitamin B1 Natural products 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- -1 carrotene Substances 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000012041 food component Nutrition 0.000 description 3
- 235000013355 food flavoring agent Nutrition 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 3
- 150000002823 nitrates Chemical class 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 235000021283 resveratrol Nutrition 0.000 description 3
- 229940016667 resveratrol Drugs 0.000 description 3
- 210000004999 sex organ Anatomy 0.000 description 3
- 230000035946 sexual desire Effects 0.000 description 3
- 231100000872 sexual dysfunction Toxicity 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 210000004336 spermatogonium Anatomy 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 3
- 235000010374 vitamin B1 Nutrition 0.000 description 3
- 239000011691 vitamin B1 Substances 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 239000000811 xylitol Substances 0.000 description 3
- 235000010447 xylitol Nutrition 0.000 description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 3
- 229960002675 xylitol Drugs 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 208000010228 Erectile Dysfunction Diseases 0.000 description 2
- 241000218231 Moraceae Species 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- BNRNXUUZRGQAQC-UHFFFAOYSA-N Sildenafil Natural products CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 BNRNXUUZRGQAQC-UHFFFAOYSA-N 0.000 description 2
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 2
- 229930003779 Vitamin B12 Natural products 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 description 2
- 240000006365 Vitis vinifera Species 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 230000009986 erectile function Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 230000035800 maturation Effects 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 230000000422 nocturnal effect Effects 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 230000001603 reducing effect Effects 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 229960002639 sildenafil citrate Drugs 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 229940094720 viagra Drugs 0.000 description 2
- 235000019163 vitamin B12 Nutrition 0.000 description 2
- 239000011715 vitamin B12 Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical group C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- GUTLYIVDDKVIGB-OUBTZVSYSA-N Cobalt-60 Chemical compound [60Co] GUTLYIVDDKVIGB-OUBTZVSYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000804384 Cynomorium songaricum Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000096284 Gynochthodes officinalis Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000130660 Hepialidae Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010024419 Libido decreased Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010057672 Male sexual dysfunction Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 241000237536 Mytilus edulis Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010061323 Optic neuropathy Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241001074085 Scophthalmus aquosus Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 235000006092 Stevia rebaudiana Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000009596 Tooth Mobility Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000003653 coastal water Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000000748 compression moulding Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000001856 erectile effect Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 229940050549 fiber Drugs 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229940068517 fruit extracts Drugs 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000020638 mussel Nutrition 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 208000020911 optic nerve disease Diseases 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000009928 pasteurization Methods 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 201000011264 priapism Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000035911 sexual health Effects 0.000 description 1
- 210000000162 simple eye Anatomy 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/90—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in food processing or handling, e.g. food conservation
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种全天然男性性促进剂及其生产工艺。该性促进剂有效成分由下述原料制成:野燕麦提取物、韭菜籽提取物、桑椹子提取物、海虹提取物、冬虫夏草提取物、核桃仁提取物。将上述原料混合均匀后压制成片,然后真空干燥使水分含量≤10%;再用无毒塑料薄膜材料密封好;最后采用钴‑60辐照灭菌。本发明的性促进剂既含有促进性功能的成分,又含有对人体有益的多种营养物质。在服用本产品时,可起到既提高性生活质量又能起到强化进补的双重作用。同时本发明使用的材料均是食品级材料,没有苦味,没有副作用及禁忌,适合所有人群口服。
Description
技术领域
本发明涉及一种全天然男性性促进剂及其生产工艺,属于保健品技术领域。
背景技术
随着经济的发展,生活水平的不断提高,人们对精神生活也越来越苛求。目前采用多种方式提高性生活质量,如食用中西药类壮阳补肾药,它也是男性功能低下者普遍采用的方法。目前,市售类补肾壮阳药物品种繁多,但多为化学制品及中西药物的复配制品。这类制品都有一定副作用。如美国产“伟哥”(万艾可)确有辅助治疗性功能低下和促进男性功能勃起的功效,但其主要成分为枸橼酸西地那非(分子式C22H30N6O4S·C6H8O7,分子量666.7)。正在服用任何剂型的硝酸酯类药的患者不能服用该产品。因为硝酸酯类药物会与枸橼酸西地那非相互作用,使降压作用增强,甚至可能使血压降至危险或危及生命。因而这类壮阳补肾药物不能用于高血压、心血管等服用硝酸酯类药物的患者,也限制了伟哥的适用范围。同时这类患者多为富贵病导致的高血压、肥胖、糖尿病等,硝酸酯类为治疗这种药的常用药。其中高血压及其伴生病患者,占了这类人群的很大比例,使“伟哥”市场份额减少,降低了其营业收入。口服伟哥类制品还会带来包括持续勃起,如不立即处理,会给人体造成永久性伤害,还会使人单眼或双眼视力突然丧失。这类眼病称之为非动脉性前部缺血性视神经病变(NAION),它是伟哥副作用的严重后果。
伟哥(万艾可)常见的副作用还有头痛、面部潮红、胃部不适、视力异常、恶心、头昏、皮疹等。因而,它不能普及到需要治疗或强化性功能的这类人群。
而一些中药补肾壮阳类制品,因有效成分含量低、口感欠佳(多数中药苦、涩),而不能为消费者所接受。中药类制品饮用前处理程序复杂,使饮用不便,也给补肾壮阳的使用带来消费市场的局限性。中药类制品因有效成分含量低,饮用者为追求效果加大饮用量,加重中草药的异味,使人们难以接受,也影响了其消费市场。有些中药给饮用者带来的副作用也十分明显,如锁阳是一种常被用来治疗肾虚的中药,但易使人上火,有升高血压的副作用。巴戟天也是一种可补肾壮阳的中药,但也有一定的毒性,在用量上有严格的规定,影响了使用效果。中草药必须针对不同体质用药,如肾阴虚的人服用肾阳虚的中药,还会造成肾功能更加受损,阴虚加重。长期服用这类中药或西药,服用量大于身体的排泄量,就会带来更严重的后果,如药物中毒。中西类药物注重药效,而缺少对人体的强化进补,使人体得不到充分的养分,越补反而越弱,对人体造成伤害。
发明内容
针对上述中西类壮阳补肾药物的缺陷,本发明提供了一种全天然男性性促进剂及其生产工艺。它采用多种营养成分全面的食品材料或药食两用材料,以不同手段提取原料的有效成分,使其有显著的药效,又含有人体必需的多种营养成分,达到既壮又补,提高性生活质量的效果。
本发明的技术方案是:一种全天然男性性促进剂,其特征是,其有效成分由下述重量份的原料制成:野燕麦提取物1-40、韭菜籽提取物1-20、桑椹子提取物1-20、海虹提取物1-30、冬虫夏草提取物1-30、核桃仁提取物1-10。
优选配比:野燕麦提取物20-40、韭菜籽提取物10-20、桑椹子提取物10-20、海虹提取物10-30、冬虫夏草提取物10-30、核桃仁提取物3-10。
其中野燕麦优选为血钻野燕麦。上述原料的含水量均为12-18%,以便于原料保存及压制成型。
制备方法:将上述原料混合均匀后压制成片,然后真空干燥(干燥温度≤60℃)使水分含量≤10%;再用无毒塑料薄膜材料密封好;最后采用钴-60辐照灭菌。
适用对象:适合于性功能低下或需要提高性功能的男性人群。
本发明还可以在此基础上加入辅料(不加也可以),如调味剂、粘合剂等。粘合剂如微晶纤维素、羟丙纤维素等,调味剂为乳糖(尤其是喷雾干燥乳糖)、木糖醇及甜叶菊等。微晶纤维素具有较强的结合力和良好的可压性。喷雾干燥法制的乳糖为球形乳糖,流动性及可压性好,同时起到调味作用。
优选的,本发明的全天然性促进剂由下述重量份的原料制成:野燕麦提取物20-40、韭菜籽提取物10-20、桑椹子提取物10-20、海虹提取物10-30、冬虫夏草提取物10-30、核桃仁提取物5-10、微晶纤维素8-12、喷雾干燥乳糖5-10。该组方的可压性好,片剂稳定性好。
优选的,本发明的全天然性促进剂由下述重量份的原料制成:野燕麦提取物20-40、韭菜籽提取物10-20、桑椹子提取物10-20、海虹提取物10-30、冬虫夏草提取物10-30、核桃仁提取物5-10、微晶纤维素8-12、木糖醇5-10。该组方适用于糖尿病人。
上述野燕麦提取物的制备方法为:在野燕麦抽穗前收割其根部以上的全部秸秆(杆、茎、叶);然后晒干或烘干(烘干时温度≤60℃);再将秸秆剪成1-10cm长段,采用浓度为50-75%的食用酒精(优选为75%)搅拌下浸提≥1小时,时间越长,浸出成分越多;过滤,将提取液浓缩除去食用酒精,并干燥使其水分含量为12-18%;然后粉碎至过10-360目筛,备用。
上述韭菜籽提取物的制备方法为:将韭菜籽净化,然后破碎至每粒2块以上(优选为2-5块,太碎了不容易滤出不溶物);以浓度≥90%的食品酒精浸泡≥1小时;过滤,将提取液浓缩除去食用酒精,并干燥使其水分含量为12-18%;然后粉碎至过10-360目筛,备用。
上述桑椹子提取物的制备方法:将桑椹子洗净,放入陶瓷质、玻璃质或食品级不锈钢容器中,以浓度≥90%的食品酒精浸泡≥1小时;过滤,将提取液(绛紫色粘稠物,含有促进新功能的有效成分白藜芦醇、脂肪酶及多种活性成分)浓缩除去食用酒精,并干燥使其水分含量为12-18%;然后粉碎至过10-360目筛,0℃以下保存备用。
上述海虹提取物的制备方法为:将海虹用≥80℃热水烫开外壳并去掉外壳,然后洗净体内泥沙;先粉碎至1-2mm后,然后加水研磨粉碎至10-360目;过滤,除去未达到上述细度的成分;并在真空、温度≤60℃条件下,干燥至水分含量12-18%,备用。
上述冬虫夏草提取物的制备方法:将冬虫夏草洗净后,先粉碎至1-2mm再加水湿磨至800目,滤去其未通过800目筛部分,并在真空、温度≤60℃条件下,干燥至水分含量12-18%,备用。
上述核桃仁提取物的制备方法为:将核桃仁先粉碎至1-2mm,再加水湿磨至800目,滤去其未通过800目筛部分,并在真空、温度≤60℃状态下,干燥至水分含量为12-18%,备用。
备注:本发明所述的酒精浓度为体积比,水分含量为质量比。本发明的真空干燥,优选在真空度-0.01~-0.05Mpa下干燥。
各原料及功能:
野燕麦:野燕麦为一种麦田杂草,多达数百种,以血钻燕麦效果较为突出。野燕麦主要含有碳水化合物、蛋白质(含有所有人体必需的氨基酸)、脂肪以及大量的植物纤维、维生素B1和维生素B12、少量的维生素E、矿物质、核黄素和皂苷。血钻野燕麦是主产于阿拉伯国家的一种野燕麦。实践证明,其成分具有有效提高男性生殖器充血量的效果。雪钻野燕麦富含多种矿物质及微量元素钾、铁、钙、镁、锌等,逐步恢复男性中枢神经和性器官微血管的活性,调节荷尔蒙,促进性器官的活性。
韭菜籽:韭菜在中医药和验方中称其为壮阳草。实践证明,韭菜确有一定的宜肾作用,补肾温阳,但无壮阳成份。其有效成分又多集中在籽实中。同时韭菜还具有降血脂及扩张血脉的作用,适用于治疗心脑血管疾病和高血压。韭菜的味道非常鲜美,还有其独特的香味。韭菜的独特辛香味是其所含的硫化物形成的,这些硫化物有一定的杀菌、消炎及提高性欲作用,有助于人体提高自身免疫力及性欲。韭菜还具有润肠通便、益肝健胃等多重功效。韭菜内含有较多的营养物质,尤其是纤维素、胡萝卜素、维生素C等都较高。
桑椹子:桑椹子为桑树成熟的果实,多为紫黑色,经检测,桑椹子中含有白藜芦醇,能抑制癌细胞生长,能阻止血液中血栓的形成,还能阻止致癌物引起的细胞突变。桑椹子中的脂肪酶能分解脂肪,降低血脂,有防止血管硬化等作用。桑椹中有多种活性成分,可以调整人体的免疫功能,促进造血细胞生长,降糖、护肝、改善皮肤血液供应,营养肌肤,促进肠液分泌和肠蠕动,防止便秘及乌发延缓衰老等功能。由于桑椹的上述多种功能,而促进人体精力充沛的健康状态。桑葚子含有丰富的活性蛋白、维生素、氨基酸、胡萝卜素、矿物质、葡萄糖、蔗糖、果糖、鞣质、苹果酸、钙、维生素B1、B2、C、尼克酸等成分,营养是苹果的5~6倍,是葡萄的4倍,具有多种功效。
海虹:又称淡菜,为近海海产。我国产量丰厚,原料来源无后顾之忧,价格低廉。海虹含有生物钙、蛋白质及多种肽类,及微量元素锌,是本发明锌的主要来源。海虹富含精氨酸和锌元素,能促进精原细胞分裂和成熟,防治男性性功能衰退。海虹类的多肽类,有促进男性内分泌的作用。海虹中的多种微量元素为人体必需。本发明有效提取了海虹中多种营养物质,使产品具备促进性功能和人体健康的作用。
冬虫夏草:冬虫夏草为麦草科冬虫夏草菌寄生在蝙蝠蛾科昆虫,幼虫中的子座及幼虫尸体的干燥复合体。冬虫夏草对免疫功能有调节作用,有一定的拟雄性激素作用和抗雌性激素样作用,而特别适宜男性性促进作用,对性功能紊乱有调节、恢复作用,使其在配方中起主导作用。冬虫夏草可以增强机体的免疫力,滋补肺肾,对肺癌、肝癌等有明显的抑制作用。冬虫夏草还具有祛痰、平喘、抗炎、抗菌、抗病毒、减慢心率、降血压、抗实验性心律失常、抗心肌缺血、降低胆固醇及甘油三酯作用。冬虫夏草的营养成分为:含有虫草酸7%,蛋白质25%,脂肪8.4%,其中82.2%为人体不能合成而又必需的不饱和脂肪酸,含有碳水化合物28.9%,游离氨基酸12种,水解液氨基酸18种。
核桃仁:核桃仁营养丰富,是世界“四大”干果之一。据测定,每百克含蛋白质14.9克,脂肪58.8克,核桃中的脂肪71%为亚油酸,12%为亚麻酸,碳水化合物9.6克,膳食纤维9.6克,胡萝卜素30微克,维生素E 43.21毫克,钾385毫克,锰3.44毫克,钙56毫克,磷294毫克,铁2.7毫克,硒4.62微克,锌2.17毫克人。就营养成分比较来说,核桃营养价值是大豆的8.5倍,花生的6倍,鸡蛋的12倍,牛奶的25倍,(1斤核桃仁相当于5斤鸡蛋或9斤牛奶的营养价值)肉类的10倍。核桃仁能补肾固精,可用于治疗肝肾亏虚惹起的各种病症,如牙齿松动、头发早白、腰腿酸软、体虚咳嗽、筋骨疼痛、小便次数增加等。
本发明针对男性性功能低下的病因着手,以野燕麦提取物、韭菜籽提取物、桑椹子提取物、海虹提取物、冬虫夏草提取物和核桃仁提取物组方。其中野燕麦提取物具有有效提高男性生殖器充血量的效果;桑椹提取物可以使人精力充沛;韭菜籽提取物补肾、提高性欲、增强免疫力的作用;海虹能促进精原细胞分裂和成熟,防治男性性功能衰退,海虹中的多肽类,有促进男性内分泌的作用;冬虫夏草提取物对性功能紊乱有调节、恢复作用,还具有益肾、增强机体免疫力、性促进作用;核桃仁提取物具有益肾固精的作用。上述原料共同组方,从强身健体(提高身体免疫力)、使男性精力充沛(精力不好则性欲低下)、益肾固精(从根源上入手)、促进精原细胞分裂和成熟(防治男性性功能衰退)、调整性功能紊乱、提高男性生殖器充血量、提高性欲等多方面入手,多方面多角度解决性功能低下的问题,并有效提高性欲。相比现有的中西类补肾壮阳药,本发明更着重于长期的效果,每日坚持服用5克左右,连续1-2月,即可使性功能低下患者保持良好的性欲1年以上。
本发明还是一种营养补充剂。本发明的野燕麦含有碳水化合物、蛋白质(含有所有人体必需的氨基酸)以及大量的植物纤维、维生素B1和维生素B12、少量的维生素E、矿物质、核黄素和皂苷。韭菜籽内含有较多的营养物质,尤其是纤维素、胡萝卜素、维生素C。桑葚子含有丰富的活性蛋白、维生素、氨基酸、胡萝卜素、矿物质、钙、维生素B1、B2、C、尼克酸等成分。海虹含有生物钙、蛋白质及多种肽类,及微量元素锌等。冬虫夏草含虫草酸、多种不饱和脂肪酸、游离氨基酸等。核桃仁中含丰富的蛋白质、亚油酸、亚麻酸、膳食纤维、胡萝卜素、维生素E、钾、锰、钙、磷、铁、硒、锌等。因此,本发明还是一种良好的营养补充剂,补充蛋白质(包括氨基酸、多肽)、维生素、矿物质、不饱和脂肪酸、胡萝卜素等。适宜于长期服用。
本发明采用多种营养成分全面的食品材料或药食两用材料,以不同手段提取原料的有效成分,使其具有显著的药效及良好的吸收效果。同时本发明的提取工艺均在低温下进行,保证其营养成分不容易流失。
本发明所采用的材料中,野燕麦和冬虫夏草微甜,韭菜籽、桑椹子、海虹和核桃仁为本身的味道,均不是苦味。以上述原料制成的性促进剂,味淡,适合口服,可以被所有服用人群所接受。也可以加入一些调味剂使它的口味更好。
本发明的有益效果是:伟哥类化学产品及一些有补肾壮阳作用的中药如霪羊藿,不含对人体需要的蛋白质、氨基酸、微量元素、维生素等营养成分或含量低微,且伟哥副作用大,中药味苦。本发明的性促进剂既含有促进性功能的成分,又含有对人体有益的多种营养物质。在服用本产品时,可起到既提高性生活质量又能起到强化进补的双重作用。同时本发明使用的材料均是食品级材料,没有苦味,没有副作用及禁忌,适合所有人群口服。
具体实施方式
实施例1:野燕麦提取
为使野燕麦中这些有效成分充分提取出来,在提取的过程中又不使这些有效成分流失,减少其份额。本发明采用如下工艺:
(1)选材:在野燕麦抽穗前收割其根部以上的全部秸秆(杆、茎、叶);
(2)对上述野燕麦材料除水备用(采用晒干或烘干的方法),烘干时温度不得超过60℃;
(3)上述秸秆为中空,需剪成1-10cm长段,以使溶剂进入秸秆内;
(4)选用材料为浓度为75%的食用酒精,搅拌浸提2小时;
(5)过滤,将提取液浓缩除去食用酒精,并干燥使其水分含量为12-18%,以利于压片成型;然后将上述提取物粉碎至过360目筛,备用。
实施例2:韭菜籽提取
(1)选用没有霉变和成熟的韭菜籽,充分净化,不得有泥土等;
(2)将韭菜籽破碎至每粒2-5块,不可太碎,以利于滤出不溶物;
(3)以浓度为95%的酒精(食品级)浸泡2小时;
(4)过滤,除去韭菜籽不溶物;
(5)浓缩除去溶剂,干燥使韭菜籽浸出物水分为12-18%;然后将上述提取物粉碎至过360目筛,备用。
实施例3:桑椹子提取
(1)取熟透、无污染的桑椹子,洗净,除去泥土等杂质;
(2)将上述桑椹子加入陶瓷质、玻璃质或食品级不锈钢容器中,以浓度为95%的酒精(食品级)浸泡2小时;除去浸泡好的桑椹子溶剂中不溶物;
(3)浓缩:桑椹子浸出液为绛紫色粘稠物,含有促进新功能的有效成分白藜芦醇、脂肪酶及多种活性成分,将其浓缩除去食用酒精,并干燥至含水量至12-18%;然后将上述提取物粉碎至过360目筛,低温存放(0℃以下),以防霉变。
实施例4:海虹提取工艺
(1)洗净外部杂质及外壳上的附着物;
(2)用80℃以上热水烫开外壳,去掉外壳,除去其体内泥沙;
(3)先粉碎至1-2mm后,然后加入5倍质量的水研磨粉碎至360目;过滤,除去未达到上述细度的成分;并在真空、温度≤60℃状态下,干燥至水分含量12-18%,备用。
注意:浓缩过程中,温度不得超过80℃,以保证其有效成分,并不得使用酒精或接触酒精。因乙醇有使蛋白质变性的作用,海虹中含人体必需的蛋白质。
实施例5:冬虫夏草提取
将冬虫夏草洗净后,先粉碎至1-2mm后加入5倍质量的水,研磨至800目,滤去其未通过800目筛部分,并以真空,温度≤60℃条件下干燥使水分降至12-18%。这一低温方式不破坏其有效成分,保持了冬虫夏草中活性成分。
实施例6:核桃仁提取
将核桃仁先粉碎至1-2mm后,加入5倍质量的水,研磨至800目,滤除未通过800目筛的杂质,以温度≤60℃、真空条件下干燥除水至水分含量12-18%,备用。
实施例7
配比:野燕麦提取物300g、韭菜籽提取物100g、桑椹子提取物100g、海虹提取物100g、冬虫夏草提取物300g、核桃仁提取物100g。各提取物制备方法见实施例1-6,水分含量均为18%。
制备方法:将上述原料混合均匀后压制成片,每片重1g;然后真空干燥(温度≤60℃)下,使水分含量≤10%;再用无毒塑料薄膜材料密封好;再采用钴-60辐照灭菌,强度为10KGy,辐照灭菌5分钟以上。上述工艺完成后,可制得1000片,每片重约1克的男性促进剂。
该促进剂灭菌温度为常温,避免了巴氏灭菌;钴-60灭菌温度高、时间长,使营养成分、活性物质药效损失的后果。由于密封后灭菌,微生物不能进入包装,与产品无机会接触而延长了保质期,保质期可达12个月。
服用方法:含化或吞咽服用。对于性功能低下者,每日2-3次,每次2-3片;1-2个月后即可显著提高性功能,并稳定1年以上。对于性功能正常促进性欲者,性生活前1小时服用,每次1-3片。
以下结合临床观察及疗效对本发明的效果进行说明。
1、研究对象:于2014年,分别对35-55岁组、55-65岁组及65-75岁组的阴茎勃起功能障碍的男性患者进行服用本发明的男性性促进剂的临床观察,每组三次重复;每重复取患者100例,共900例患者;
2、诊断标准:参照国际勃起功能评分表(IIEF-5)进行评分,评分小于7分为重度勃起功能障碍,8-11分为中度勃起功能障碍,12-21分为轻度勃起功能障碍;
3、服用方法:每日2-3次,每次2-3片;连服1个月后观察疗效;
4、观察方法:填写IIEF-5表,根据问卷表中列出的阴茎勃起功能的5个问题,由患者在治疗前后分别独立问答;问卷中每一个问题的回答均按5分制表示,5分为最好,1分为最差,0分为未尝试性交;
5、疗效评定:IIEF-5改善大于4分为有效,其余为无效。
6、治疗结果如表1所示。
全天然男性性促进剂功能试验表
实施例8
配比:野燕麦提取物300g、韭菜籽提取物150g、桑椹子提取物100g、海虹提取物200g、冬虫夏草提取物200g、核桃仁提取物50g。各提取物制备方法见实施例1-6,水分含量均为16%。
制备方法:将上述原料混合均匀后压制成片,然后真空干燥(干燥温度≤60℃)下,使水分含量≤10%;再用无毒塑料薄膜材料密封好;再采用钴-60辐照灭菌,强度为10KGy,辐照灭菌5分钟以上。上述工艺完成后,可获得1000片,每片重约1g的男性功能促进剂。
实施例9
配比:野燕麦提取物200g、韭菜籽提取物100g、桑椹子提取物100g、海虹提取物200g、冬虫夏草提取物200g、核桃仁提取物50g、微晶纤维素100g、喷雾干燥乳糖50g。各提取物制备方法见实施例1-6,水分含量均为12%。
制备方法:将上述原料混合均匀后压制成片,然后真空干燥(干燥温度≤60℃)下,使水分含量≤10%;再用无毒塑料薄膜材料密封好;再采用钴-60辐照灭菌。强度为10KGy,辐照灭菌5分钟以上。上述工艺完成后,可获得1000片,每片重约1.0g的男性功能促进剂。
实施例10
配比:野燕麦提取物300g、韭菜籽提取物100g、桑椹子提取物100g、海虹提取物150g、冬虫夏草提取物150g、核桃仁提取物50g、微晶纤维素100g、木糖醇50g。各提取物制备方法见实施例1-6,水分含量均为15%。
制备方法:将上述原料混合均匀后压制成片,然后真空干燥(干燥温度≤60℃)下,使水分含量≤10%;再用无毒塑料薄膜材料密封好;再采用钴-60辐照灭菌。强度为10KGy,辐照灭菌5分钟以上。上述工艺完成后,可获得1000片,每片重约1.0g的男性功能促进剂。
Claims (8)
1.一种全天然男性性促进剂,其特征是,其有效成分由下述重量份的原料制成:野燕麦提取物20-40、韭菜籽提取物10-20、桑椹子提取物10-20、海虹提取物10-30、冬虫夏草提取物10-30、核桃仁提取物3-10;
所述野燕麦提取物的制备方法为:在野燕麦抽穗前收割其根部以上的全部秸秆;然后晒干或烘干;再将秸秆剪成1-10cm长段,采用浓度为50-75%的食用酒精搅拌下浸提≥1小时;过滤,将提取液浓缩除去食用酒精,并干燥使其水分含量为12-18%;然后粉碎至过10-360目筛,备用;
所述韭菜籽提取物的制备方法为:将韭菜籽净化,然后破碎至每粒2块以上;以浓度≥90%的食品酒精浸泡≥1小时;过滤,将提取液浓缩除去食用酒精,并干燥使其水分含量为12-18%;然后粉碎至过10-360目筛,备用;
所述桑椹子提取物的制备方法:将桑椹子洗净,放入陶瓷质、玻璃质或食品级不锈钢容器中,以浓度≥90%的食品酒精浸泡≥1小时;过滤,将提取液浓缩除去食用酒精,并干燥使其水分含量为12-18%;然后粉碎至过10-360目筛,0℃以下保存备用。
2.如权利要求1所述的一种全天然男性性促进剂,其特征是,所述野燕麦为血钻野燕麦。
3.如权利要求1或2所述的一种全天然男性性促进剂,其特征是,所述原料的含水量均为12-18%。
4.如权利要求1所述的一种全天然男性性促进剂,其特征是,所述韭菜籽破碎至每粒2-5块。
5.如权利要求3所述的一种全天然男性性促进剂,其特征是,所述海虹提取物的制备方法为:将海虹用≥80℃热水烫开外壳并去掉外壳,然后洗净体内泥沙;先粉碎至1-2mm后,然后加水研磨粉碎至10-360目;过滤,除去未达到上述细度的成分;并在真空、温度≤60℃条件下,干燥至水分含量12-18%,备用。
6.如权利要求3所述的一种全天然男性性促进剂,其特征是,所述冬虫夏草提取物的制备方法:将冬虫夏草洗净后,先粉碎至1-2mm再加水湿磨至800目,滤去其未通过800目筛部分,并在真空、温度≤60℃条件下,干燥至水分含量12-18%,备用。
7.如权利要求3所述的一种全天然男性性促进剂,其特征是,所述核桃仁提取物的制备方法为:将核桃仁先粉碎至1-2mm,再加水湿磨至800目,滤去其未通过800目筛部分,并在真空、温度≤60℃状态下,干燥至水分含量为12-18%,备用。
8.如权利要求3所述的全天然男性性促进剂的生产工艺,其特征是,将原料混合均匀后压制成片,然后真空干燥,干燥温度≤60℃,使水分含量≤10%;再用无毒塑料薄膜材料密封好;最后采用钴-60辐照灭菌。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510390635.1A CN105012727B (zh) | 2015-07-06 | 2015-07-06 | 一种全天然男性性促进剂及其生产工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510390635.1A CN105012727B (zh) | 2015-07-06 | 2015-07-06 | 一种全天然男性性促进剂及其生产工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105012727A CN105012727A (zh) | 2015-11-04 |
CN105012727B true CN105012727B (zh) | 2018-08-07 |
Family
ID=54403267
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510390635.1A Expired - Fee Related CN105012727B (zh) | 2015-07-06 | 2015-07-06 | 一种全天然男性性促进剂及其生产工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105012727B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105520131A (zh) * | 2015-12-09 | 2016-04-27 | 刘传新 | 一种男性性功能促进剂及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1249938A (zh) * | 1998-10-05 | 2000-04-12 | 王平 | 填精补髓丸 |
CN104491658A (zh) * | 2014-12-30 | 2015-04-08 | 兰州古驰生物科技有限公司 | 一种用于调理男性早泄的中药制剂 |
-
2015
- 2015-07-06 CN CN201510390635.1A patent/CN105012727B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1249938A (zh) * | 1998-10-05 | 2000-04-12 | 王平 | 填精补髓丸 |
CN104491658A (zh) * | 2014-12-30 | 2015-04-08 | 兰州古驰生物科技有限公司 | 一种用于调理男性早泄的中药制剂 |
Non-Patent Citations (1)
Title |
---|
性保健的饮食略述;姚海扬;《东方食疗与保健》;20060601(第06期);第48页右边栏第3段,第49页右边栏第5、7段,第50页左边栏第1段,第51页右边栏第2段 * |
Also Published As
Publication number | Publication date |
---|---|
CN105012727A (zh) | 2015-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101738912B1 (ko) | 비만억제 및 다이어트 조성물 | |
KR101433188B1 (ko) | 아미노산, 활성종합비타민 및 한방생약재를 함유하는 숙취해소용 조성물 및, 그 제조방법 | |
KR101541516B1 (ko) | 누에와 뽕나무잎과 상지(桑枝)를 주원료로한 이온미네랄 건강음료의 제조방법 | |
KR100902539B1 (ko) | 전복엑기스를 함유하는 기능성 음료조성물과 그 제조방법 | |
KR20030020908A (ko) | 천연 생약 발효를 이용한 화장품 조성물 | |
KR102136052B1 (ko) | 허브추출물을 유효성분으로 하는 간기능보호용 조성물 및 이를 함유하는 음료 | |
KR101018065B1 (ko) | 대추를 사용한 건강음료 제조방법 및 이에 의해 제조된 건강음료 | |
KR100703897B1 (ko) | 약초 성분을 주원료로 한 음료 및 그 제조방법 | |
KR20090098024A (ko) | 약주의 제조방법 | |
KR20100082689A (ko) | 월드 인삼 조성물과 그 제조방법 | |
KR20010100562A (ko) | 수제용 약차와 약술의 제조방법 | |
KR102577074B1 (ko) | 원형 그대로의 반려동물용 수산물 수제 간식의 제조 방법 및 이를 이용하여 제조된 원형 그대로의 반려동물용 수산물 수제 간식 | |
CN106538908A (zh) | 一种改善睡眠的葡萄饮品及制作方法 | |
CN105029553A (zh) | 一种果汁蛋钙中药保健饮料及其制备方法 | |
KR101788253B1 (ko) | 고량강, 풀솜대 및 흑마늘을 유효성분으로 포함하는 남성 성기능 개선용 조성물 | |
KR102238009B1 (ko) | 노니가 함유된 홍삼 가공품 및 이의 제조방법 | |
KR20110056908A (ko) | 다시마, 함초, 귤피, 당귀, 옥수수수염, 뽕잎 및 삼백초으로 이루어진 한방 혼합 침출차 조성물 및 그 제조방법 | |
CN105012727B (zh) | 一种全天然男性性促进剂及其生产工艺 | |
CN107384680B (zh) | 一种百香果龙眼果酒及其酿造方法 | |
CN108187032A (zh) | 虫草胶原蛋白肽片 | |
KR100568604B1 (ko) | 수산물 통조림 및 그 가공방법 | |
CN106222012A (zh) | 一种缓解风湿的无花果酒 | |
KR20070005317A (ko) | 땅감자를 주원료로 한 당뇨환자용 건강보조식품 | |
KR102050554B1 (ko) | 숙취해소용 액상차 조성물 및 이의 제조 방법 | |
KR20100082688A (ko) | 월드 홍삼 조성물과 그 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180807 Termination date: 20190706 |
|
CF01 | Termination of patent right due to non-payment of annual fee |